EUVIMEDScopri EUVIMED
EditorialOpen access

Editorial on ‘Lowering the C‐Reactive Protein ( CRP ) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis’

Molly Bradbury iD, Jonathan Tyrrell-Price iD

Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 1005-1006

DOI: 10.1111/apt.70849 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-07-18. Written by Molly Bradbury and 1 co-authors. Institution: University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK. Cited 1 times so far (Crossref); 3 references. The full text is freely available in PubMed Central.

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Abstract non disponibile.

Authors and institutions

  • University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.

ORCID profiles: Molly Bradbury, Jonathan Tyrrell-Price

Cite

APA

Bradbury, M., & Tyrrell-Price, J. (2026). Editorial on ‘Lowering the C‐Reactive Protein ( CRP ) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis’. Alimentary Pharmacology & Therapeutics, 64(7), 1005-1006. https://doi.org/10.1111/apt.70849

Vancouver

Bradbury M, Tyrrell-Price J. Editorial on ‘Lowering the C‐Reactive Protein ( CRP ) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis’. Alimentary Pharmacology & Therapeutics. 2026;64(7):1005-1006. doi:10.1111/apt.70849

BibTeX
@article{Bradbury2026,
  author = {Bradbury, Molly and Tyrrell-Price, Jonathan},
  title = {Editorial on ‘Lowering the C‐Reactive Protein ( CRP ) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis’},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {7},
  pages = {1005--1006},
  doi = {10.1111/apt.70849}
}
Start for free →